References
- Aboulghar M A, Mansour R T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275–289
- Elchalal U, Schelcer J G. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 1997; 12: 1129–1137
- Artini P G, Monti M, Fasciani A, Battaglia C, D'Ambrogio G, Genazzani A R. Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 2002; 101: 169–174
- D'Ambrogio G, Fasciani A, Monti M, Cattani R, Genazzani A R, Artini P G. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. Gynecol Endocrinol 1999; 13: 311–315
- Pellicer A, Albert C, Marcade A, Musoles F, Ramohi J, Simon C. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1B, interleukin-6, and vascular endothelial growth factor. Fertil Steril 1999; 71: 482–489
- Golan A, Ron-El R, Herman A. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430–440
- Aboulghar M A, Mansour R T, Serour G I, Amin Y. Ultrasonographic guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 1990; 53: 933–935
- Raziel A, Friedler S, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Transvaginal drainage of ascites as an alternative to abdominal paracentesis in patients with severe ovarian hyperstimulation syndrome, obesity, and generalized edema. Fertil Steril 1998; 69: 780–783